市场调查报告书
商品编码
1351550
尿液分析市场规模 - 按产品(消耗品、仪器)、按应用(泌尿道感染[UTI]、肾臟疾病、怀孕、糖尿病)、按最终用途(临床实验室、医院、家庭保健)、全球预测2023 - 2032 年Urinalysis Market Size - By Product (Consumables, Instruments), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pregnancy, Diabetes), By End-Use (Clinical Laboratories, Hospitals, Home Healthcare), Global Forecast 2023 - 2032 |
2023-2032 年全球尿液分析市场复合年增长率将达 5.2%。这是由于泌尿道感染和肾臟疾病的盛行率不断增加。
据 CDC 称,美国有近 3550 万成年人患有慢性肾臟病。这推动了对尿液分析测试作为诊断工具的需求,从而推动市场成长。全球人口老化也导致慢性病发生率上升,因此需要定期进行尿液监测。不断提高的医疗保健意识和积极的预防性医疗保健措施进一步推动了常规尿液检测的采用。发展中地区医疗保健基础设施的扩大以及对早期疾病检测的日益重视可能会进一步推动市场扩张,使尿液分析成为现代医疗保健的重要组成部分。
整个尿液分析市场根据产品、应用、最终用途和地区进行分类。
根据产品,从2023 年到2032 年,仪器细分市场的复合年增长率将达到6.4%。随着泌尿道感染和慢性肾臟疾病盛行率的不断增加,人们对早期疾病检测重要性的认识不断增强,这将刺激对尿液分析仪器的需求,从而加速细分市场的成长。
糖尿病应用领域的尿液分析产业预计 2023 年至 2032 年复合年增长率为 9.3%。全球糖尿病流行不断升级将推动该领域未来几年的成长。不断增加的糖尿病患者人数正在增加对尿糖和酮检测的需求,并强调尿液分析在糖尿病管理和监测中的重要作用。
按最终用途划分,临床实验室领域预计在整个预测期内复合年增长率为 5.9%。对常规健康检查的需求不断增加、疾病盛行率不断上升、诊断技术的进步以及预防性医疗保健的日益增长的趋势将推动尿液分析程序在临床实验室中的采用。
从地区来看,从2023 年到2032 年,拉丁美洲(LATAM) 尿液分析行业将以4.3% 的复合年增长率增长。这一增长归因于医疗保健支出的增加和医疗保健服务范围的扩大。人口老化的加剧、预防保健意识的增强以及慢性病发病率的上升也推动了该地区对尿液分析检测和服务的需求。
Global urinalysis market will reflect 5.2% CAGR over 2023-2032. This is attributed to the increasing prevalence of urinary tract infections and kidney diseases.
According to the CDC, nearly 35.5 million adults in the U.S. suffer from chronic kidney disease. This is propelling the demand for urinalysis tests as a diagnostic tool which will propel market growth. The aging global population is also contributing to a higher incidence of chronic diseases, necessitating regular urine monitoring. Rising healthcare awareness and proactive preventive healthcare measures are further boosting the adoption of routine urine testing. Expanding healthcare infrastructure in developing regions and the growing emphasis on early disease detection may further drive market expansion, making urinalysis a vital component of modern healthcare.
The overall urinalysis market is categorized based on product, application, end-use and region.
Based on product, the instrument segment will exhibit a 6.4% CAGR from 2023 to 2032. Growing awareness about the importance of early disease detection alongside the increasing prevalence of urinary tract infections and chronic kidney diseases will fuel demand for urinalysis instruments, accelerating segment growth.
Urinalysis industry from the diabetes application segment is expected to witness a 9.3% CAGR from 2023 to 2032. The escalating global diabetes epidemic will drive the segment growth in the forthcoming years. Increasing diabetic patient populations are boosting the demand for urine glucose and ketone testing, emphasizing the vital role of urinalysis in diabetes management and monitoring.
By end-use, clinical laboratories segment is expected to grow at a 5.9% CAGR throughout the forecast period. The increasing demand for routine health check-ups, rising disease prevalence, advancements in diagnostic technology, and the growing trend towards preventive healthcare will drive the adoption of urinalysis procedures in clinical laboratories.
Regionally, the Latin American (LATAM) urinalysis industry will grow at a 4.3% CAGR from 2023 to 2032. The growth is attributed to rising healthcare expenditure and expanding access to healthcare services. An increase in the aging population, growing awareness of preventive healthcare, and the rising incidence of chronic diseases are also boosting demand for urinalysis tests and services in the region.